LINC01734

Across TCGA pan-cancer cohorts, LINC01734 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated LINC01734 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher LINC01734 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01734 expression acts as an unfavorable survival marker, although some lineages such as KIRC show a favorable association.

OV, KIRP, and LIHC are the cancer types where LINC01734 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	IV	0.028	0.759	.002	84	view →
KIRP	OS	Tertile	All	0.692	0.954	<.001	84	view →
LIHC	OS	Tertile	II,III,IV	0.033	0.697	<.001	42	view →
KIRC	DFS	Tertile	III,IV	1.000	0.411	.022	36	view →
ACC	OS	Tertile	All	0.114	0.892	<.001	36	view →
DLBC	OS	Tertile	III,IV	0.154	0.735	.010	28	view →
SKCM	DFS	Tertile	IV	0.016	0.454	<.001	24	view →
THYM	DFS	Tertile	All	0.572	0.921	.007	18	view →
THCA	DFS	Tertile	III,IV	0.081	0.738	<.001	18	view →
PRAD	OS	Tertile	All	0.876	0.996	<.001	12	view →
GBM	DFS	Tertile	All	0.080	0.246	.019	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

LINC01734–OV (OS)

Open the OV breakdown →